Skip to main content

Table 1 Univariate analysis results of training group patients [n (%)]

From: Construction and validation of a nomogram model for predicting the risk of recurrence in patients with lower extremity arteriosclerosis obliterans after surgical intervention

Characteristics

Relapse group(n = 76)

Non-recurrence group(n = 113)

P value

Gender

  

> 0.05

 Female

32 (42.11)

43(33.59%)

 

 Male

44 (57.89)

85(66.41%)

 

Age (years)

  

< 0.05

 < 60

24(31.58)

59(52.21)

 

 ≥ 60

52(68.42)

54(47.79)

 

BMI ≥ 24 kg/m2

46 (60.53)

53(46.90)

< 0.05

Smoking history

53(69.74)

71(62.83)

> 0.05

Drinking history

51(67.11)

74(65.49)

> 0.05

Diabetes

54(71.05)

61(53.98)

< 0.05

Hypertension

56(73.68)

62(54.87)

< 0.05

Coronary heart disease

49(64.47)

70(61.95)

> 0.05

Hyperlipidemia

47(61.84)

71(62.83)

> 0.05

 Renal insufficiency

45(59.21)

72(63.72)

 

 Ischemic stroke

44(57.89)

68(60.18)

 

Classification of lesion location

  

< 0.05

 Aortoiliac disease

21(27.63)

46(40.71)

 

 Femoropopliteal disease

12(15.79)

33(29.20)

 

 Surrounding type

43(56.58)

34(30.09)

 

Pathological side (left side)

51(67.11)

73(64.60)

> 0.05

Lower limb arterial ulcer

33(43.42)

51(45.13)

> 0.05

Disease length/cm

7.93 ± 0.56

8.04 ± 0.67

> 0.05

TASC classification

  

> 0.05

 A ~ B

20(26.32)

32(28.32)

 

 C ~ D

56(73.68)

81(71.68)

 

Calcification degree

  

> 0.05

 No calcification

21(27.63)

31(27.43)

 

 mild calcification

41(53.95)

60(53.10)

 

 Severe calcification

14(18.42)

22(19.47)

 

Interventional procedure/

  

> 0.05

 Simple balloon dilation

27(35.53)

40(35.40)

 

 Balloon dilation + stent implantation

49(64.47)

73(64.60)

 

Antiplatelet drugs(used)

36(47.37)

82(72.57)

< 0.05

Hb /(g/L)

131.41 ± 17.12

129.42 ± 16.34

> 0.05

TC/(mmol/L)

4.81 ± 0.87

4.76 ± 0.80

> 0.05

TG/(mmol/L)

2.94 ± 0.56

1.70 ± 0.51

< 0.05

FIB/(g/L)

3.56 ± 0.55

3.02 ± 0.51

< 0.05

D-D/(mg/L)

0.76 ± 0.11

0.49 ± 0.09

< 0.05

PT/(s)

11.86 ± 2.12

12.06 ± 2.41

> 0.05

PLT/(×109/L)

255.13 ± 42.67

247.25 ± 40.87

> 0.05

TT/(s)

15.93 ± 4.22

16.21 ± 4.35

> 0.05

WBC/(×109/L)

7.71 ± 2.07

7.66 ± 2.11

> 0.05

  1. BMI: Body Mass Index; TASC: Trans-Atlantic Inter-Society Consensus; Hb: Hemoglobin; TC: Total Cholesterol; TG: Triglyceride; FIB: Fibrinogen; D-D: D-dimer; PT: Prothrombin Time; PLT: Platelet; TT: Thrombin Time; WBC: White Blood Cell